Business
Press Release Nov 21 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Strides receives USFDA approval for Levetiracetam Oral Solution".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Strides receives USFDA approval for Levetiracetam Oral Solution". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd